Invesco Ltd. Biotechnology

Invesco Ltd.

$503 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ABCL Ab Cellera Biologics Inc.	$1.03B	$53,000 0.0% of portfolio	24,146	Q1 2025 Added 114.57%
CRBU Caribou Biosciences, Inc.	$82.7M	$53,000 0.0% of portfolio	58,974	Q1 2025 Reduced 10.23%
HUMA Humacyte, Inc.	$232M	$51,000 0.0% of portfolio	30,145	Q1 2025 Reduced 2.53%
RGLS Regulus Therapeutics Inc.	$119M	$51,000 0.0% of portfolio	29,460	Q1 2025 Reduced 2.61%
AUTL Autolus Therapeutics PLC	$210M	$50,000 0.0% of portfolio	32,738	Q1 2025 Added 53.29%
GOSS Gossamer Bio, Inc.	$117M	$48,000 0.0% of portfolio	43,697	Q1 2025 New
ALXO Alx Oncology Holdings Inc	$17.9M	$45,000 0.0% of portfolio	73,836	Q1 2025 New
DSGN Design Therapeutics, Inc.	$199M	$43,000 0.0% of portfolio	11,331	Q1 2025 Reduced 2.18%
IGMS Igm Biosciences, Inc.	$31.3M	$41,000 0.0% of portfolio	36,127	Q1 2025 New
ATOS Atossa Therapeutics, Inc.	$115M	$39,000 0.0% of portfolio	58,669	Q1 2025 Reduced 2.78%
MRSN Mersana Therapeutics, Inc.	$32.1M	$39,000 0.0% of portfolio	114,863	Q1 2025 Added 109.33%
IMUX Immunic, Inc.	$21.4M	$38,000 0.0% of portfolio	35,409	Q1 2025 Reduced 3.81%
LRMR Larimar Therapeutics, Inc.	$131M	$34,000 0.0% of portfolio	16,112	Q1 2025 Reduced 0.91%
CVAC Cure Vac N.V.	$1.01B	$34,000 0.0% of portfolio	12,376	Q1 2025 Added 7.24%
VERU Veru Inc.	$46.5M	$30,000 0.0% of portfolio	61,961	Q1 2025 Reduced 4.35%
TCRX T Scan Therapeutics, Inc.	$27.3M	$28,000 0.0% of portfolio	20,590	Q1 2025 Reduced 0.18%
PROK Prokidney Corp Ord Shs Cl A(Cy	$41.2M	$28,000 0.0% of portfolio	32,258	Q1 2025 Added 0.42%
LCTX Lineage Cell Therapeutics, Inc.	$166M	$26,000 0.0% of portfolio	58,038	Q1 2025 Reduced 6.06%
APLT Applied Therapeutics Inc.	$15.4M	$25,000 0.0% of portfolio	51,098	Q1 2025 Reduced 4.49%
PYXS Pyxis Oncology, Inc.	$40.4M	$24,000 0.0% of portfolio	24,805	Q1 2025 Reduced 2.21%
PRQR Pro Qr Therapeutics N.V.	$150M	$24,000 0.0% of portfolio	18,084	Q1 2025 Added 52.13%
BMEA Biomea Fusion, Inc.	$55.4M	$23,000 0.0% of portfolio	10,959	Q1 2025 Reduced 5.59%
SAVA Cassava Sciences Inc	$70.2M	$19,000 0.0% of portfolio	13,117	Q1 2025 Reduced 14.87%
INZY Inozyme Pharma, Inc.	$161M	$17,000 0.0% of portfolio	19,315	Q1 2025 Reduced 2.97%
STTK Shattuck Labs, Inc.	$42.4M	$17,000 0.0% of portfolio	18,908	Q1 2025 Added 0.97%
ADAP Adaptimmune Therapeutics PLC	$37.6M	$15,000 0.0% of portfolio	78,031	Q1 2025 Added 23.2%
NAUT Nautilus Biotechnology, Inc.	$96M	$14,000 0.0% of portfolio	17,101	Q1 2025 Reduced 4.36%
HOWL Werewolf Therapeutics, Inc.	$31.9M	$13,000 0.0% of portfolio	14,232	Q1 2025 Reduced 2.45%
XFOR X4 Pharmaceuticals, Inc	$126M	$13,000 0.0% of portfolio	58,187	Q1 2025 Reduced 6.26%
OVID Ovid Therapeutics Inc.	$23.9M	$8,000 0.0% of portfolio	27,207	Q4 2024 Reduced 7.26%
ELEV Elevation Oncology, Inc.	$8.39M	$6,000 0.0% of portfolio	25,113	Q1 2025 Added 1.28%
TNYA Tenaya Therapeutics, Inc.	$27.7M	$6,000 0.0% of portfolio	12,209	Q1 2025 Reduced 5.18%
GBIO Generation Bio Co.	$21.2M	$5,000 0.0% of portfolio	13,536	Q1 2025 Reduced 5.75%
LYRA Lyra Therapeutics, Inc.	$295M	$3,000 0.0% of portfolio	23,626	Q4 2024 Added 4.29%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	29,949	Q1 2025 Added 49.83%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.